AbbVie Inc. News Headlines

ABBV 
$65.19
*  
0.31
0.47%
Get ABBV Alerts
*Delayed - data as of Nov. 20, 2014  -  Find a broker to begin trading ABBV now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Achillion Pharmaceuticals: Still Bullish, But Taking Profits
11/12/2014 5:06:00 PM - Seeking Alpha


Gilead Reports Promising Data on its HCV Drug Harvoni - Analyst Blog
11/12/2014 5:00:00 PM - Zacks.com


Gilead Sciences Gets Ambushed By The Patent Troll, AbbVie
11/12/2014 3:25:00 PM - Seeking Alpha


Regeneron/Sanofi Announce Positive Dupilumab Study Data - Analyst Blog
11/12/2014 11:00:00 AM - Zacks.com


Earnings Triple Plays
11/12/2014 2:54:00 AM - Seeking Alpha


SUPN Revises Revenue Outlook Upward, EVDY Fit And Fine, NASDAQ Warning For ACST
11/11/2014 10:40:00 PM - RTT News


SUPN Revises Revenue Outlook Upward, EVDY Fit And Fine, NASDAQ Warning For ACST
11/11/2014 10:40:00 PM - RTT News


Bristol-Myers Gives Updates on HCV Candidate Daclatasvir - Analyst Blog
11/11/2014 6:41:00 PM - Zacks.com


Galapagos - AbbVie's Best Bet For Staying Market Leader In Rheumatoid Arthritis Post Humira?
11/11/2014 3:45:00 PM - Seeking Alpha


Re-Examining My Bullish Thesis On Walgreen
11/11/2014 2:04:00 PM - Seeking Alpha


Why Is Gilead Always Holding The Ace? A Prediction Of The Future HCV Market And What Analysts Aren't Talking About
11/11/2014 11:13:00 AM - Seeking Alpha


Gilead presents Harvoni data
11/11/2014 11:03:00 AM - Seeking Alpha


Are Expensive Biotech Drugs Bad For Business?
11/11/2014 10:45:00 AM - Seeking Alpha


Stock Market News for November 11, 2014 - Market News
11/11/2014 10:10:00 AM - Zacks.com


AbbVie Reports Results From Studies In Hepatitis C Patients - Quick Facts
11/11/2014 9:28:00 AM - RTT News


Gilead presents data from three HCV drug combo studies
11/11/2014 9:05:00 AM - Seeking Alpha


Repros Soars on Positive FDA Meeting Regarding Androxa - Analyst Blog
11/10/2014 5:20:00 PM - Zacks.com


Merck Reports Interim Data on Hepatitis C Virus Drug - Analyst Blog
11/10/2014 4:45:00 PM - Zacks.com


Closing Update: Stocks Eke Out Gains as Transports Fuel Another Higher Close
11/10/2014 4:20:15 PM - MT Newswires


Emergent BioSolutions Beats on Q3 Earnings, Guidance Up - Analyst Blog
11/10/2014 12:30:00 PM - Zacks.com


Merck's Shortened Hep C Regimens Fall Short of Cure-Rate Goal
11/9/2014 6:23:00 PM - TheStreet


Google's "Cancer Pill": Revolutionary or Ridiculous?
11/9/2014 2:24:02 PM - Motley Fool


3 Biotech Stocks to Watch in November
11/8/2014 11:03:17 AM - Motley Fool


Gilead (GILD) Submits HIV Combination Drug for FDA Review - Analyst Blog
11/7/2014 6:50:00 PM - Zacks.com


Novartis' (NVS) LBH589 Gets Unfavorable FDA Panel Opinion - Analyst Blog
11/7/2014 5:20:00 PM - Zacks.com